{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:20:50Z","timestamp":1790882450671,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Existing literature has not clearly elucidated whether SARS-CoV-2 infection increases the incidence of Parkinson\u2019s disease or if Parkinson\u2019s disease patients are more susceptible to the effects of SARS-CoV-2 infection. To clarify the issue, this study employs a genetic epidemiological approach to investigate the association.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study utilizes a two-sample Mendelian randomization analysis. The primary analysis employs the inverse variance-weighted (IVW) method, supplemented by secondary analyses including MR-Egger regression, weighted median, IVW radial method, and weighted mode, to evaluate the bidirectional causal relationship between Parkinson\u2019s disease and SARS-CoV-2 infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>IVW results showed no genetic causality between SARS-CoV-2 susceptibility, hospitalization rate and severity and Parkinson\u2019s disease. (IVW method: <jats:italic>p<\/jats:italic>\u2009=\u20090.408 OR\u2009=\u20091.10 95% CI: 0.87\u2009~\u20091.39; <jats:italic>p<\/jats:italic>\u2009=\u20090.744 OR\u2009=\u20091.11 95% CI: 0.94\u2009~\u20091.09; <jats:italic>p<\/jats:italic>\u2009=\u20090.436 OR\u2009=\u20091.05 95% CI: 0.93\u2009~\u20091.17). Parkinson\u2019s disease was not genetically associated with susceptibility to new crown infections, hospitalization rates, and severity (IVW method: <jats:italic>p<\/jats:italic>\u2009=\u20090.173 OR\u2009=\u20091.01 95% CI: 0.99\u2009~\u20091.03; <jats:italic>p<\/jats:italic>\u2009=\u20090.109 OR\u2009=\u20091.05 95% CI: 0.99\u2009~\u20091.12; <jats:italic>p<\/jats:italic>\u2009=\u20090.209 OR\u2009=\u20091.03 95% CI: 0.99\u2009~\u20091.07). MR-Egger regression, weighted median, IVW radial method, and weighted mode results are consistent with the results of the IVW method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study does not support a genetic link between Parkinson\u2019s disease and SARS-CoV-2 infection, and the association observed in previous cohort studies and observational studies may be due to other confounding factors.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1393888","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T04:54:13Z","timestamp":1719550453000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["No genetic link between Parkinson\u2019s disease and SARS-CoV-2 infection: a two-sample Mendelian randomization study"],"prefix":"10.3389","volume":"15","author":[{"given":"Xiaohua","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yida","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/mds.28118","article-title":"Can the 2019 novel coronavirus cause Parkinson's disease?","volume":"35","author":"Achbani","year":"2020","journal-title":"Mov Disord"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/YCO.0000000000000688","article-title":"Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?","volume":"34","author":"McAlpine","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.26355\/eurrev_202206_29093","article-title":"COVID-19 and neurodegenerative diseases","volume":"26","author":"Fu","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e28107","DOI":"10.1002\/jmv.28107","article-title":"Causal effect of COVID-19 on Alzheimer's disease: a Mendelian randomization study","volume":"95","author":"Baranova","year":"2023","journal-title":"J Med Virol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1007\/s00415-021-10721-4","article-title":"Covid-19 and Parkinson's disease: an overview","volume":"268","author":"Cartella","year":"2021","journal-title":"J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/biom12070970","article-title":"COVID-19 and parkinsonism: a critical appraisal","volume":"12","author":"Cavallieri","year":"2022","journal-title":"Biomol Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S1474-4422(20)30305-7","article-title":"A case of probable Parkinson's disease after SARS-CoV-2 infection","volume":"19","author":"Cohen","year":"2020","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41531-020-00123-0","article-title":"COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside","volume":"6","author":"Sulzer","year":"2020","journal-title":"NPJ Parkinsons Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1007\/s12031-022-02068-w","article-title":"Discovering common pathogenic mechanisms of COVID-19 and Parkinson disease: an integrated bioinformatics analysis","volume":"72","author":"Jahanimoghadam","year":"2022","journal-title":"J Mol Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/ene.15732","article-title":"Parkinson disease following COVID-19: report of six cases","volume":"30","author":"Calculli","year":"2023","journal-title":"Eur J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"106349","DOI":"10.1016\/j.clineuro.2020.106349","article-title":"Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: a systematic review","volume":"200","author":"Kubota","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"afac277","DOI":"10.1093\/ageing\/afac277","article-title":"Excess deaths from Alzheimer's disease and Parkinson's disease during the COVID-19 pandemic in the USA","volume":"51","author":"Li","year":"2022","journal-title":"Age Ageing"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.parkreldis.2021.07.002","article-title":"Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran","volume":"89","author":"Salari","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/mds.28586","article-title":"Clinical profiles and mortality of COVID-19 inpatients with Parkinson\u2019s disease in Germany","volume":"36","author":"Scherbaum","year":"2021","journal-title":"Mov Disord"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mds.28408","article-title":"Risk of hospitalization and death for COVID-19 in people with Parkinson's disease or parkinsonism","volume":"36","author":"Vignatelli","year":"2021","journal-title":"Mov Disord"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e2278","DOI":"10.1002\/rmv.2278","article-title":"The impact of Parkinson's disease on manifestations and outcomes of COVID-19 patients: a systematic review and meta-analysis","volume":"32","author":"El\u2010Qushayri","year":"2022","journal-title":"Rev Med Virol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"a041302","DOI":"10.1101\/cshperspect.a041302","article-title":"Mendelian randomization","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12916-023-02894-8","article-title":"Standardizing the reporting of Mendelian randomization studies","volume":"21","author":"Au","year":"2023","journal-title":"BMC Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/bs.irn.2022.04.004","article-title":"Covid-19 and Parkinson's disease: acute clinical implications, long-COVID and post-COVID-19 parkinsonism","volume":"165","author":"Leta","year":"2022","journal-title":"Int Rev Neurobiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson's disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","article-title":"Viral parkinsonism","volume":"1792","author":"Jang","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"573095","DOI":"10.3389\/fneur.2020.573095","article-title":"The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains","volume":"11","author":"Chen","year":"2020","journal-title":"Front Neurol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1002\/mds.28680","article-title":"COVID-19 infection and parkinsonism: is there a link?","volume":"36","author":"Bouali-Benazzouz","year":"2021","journal-title":"Mov Disord"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s13365-021-00998-6","article-title":"A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system","volume":"27","author":"Williams","year":"2021","journal-title":"J Neurovirol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fncom.2013.00013","article-title":"The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease","volume":"7","author":"Pissadaki","year":"2013","journal-title":"Front Comput Neurosci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00415-020-10002-6","article-title":"Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region","volume":"268","author":"del Prete","year":"2021","journal-title":"J Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/jnnp-2021-326286","article-title":"Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong","volume":"92","author":"Fan","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.parkreldis.2021.04.019","article-title":"Parkinson\u2019s disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: a systematic review, meta-analysis, and meta-regression","volume":"87","author":"Putri","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s13760-022-02141-6","article-title":"COVID-19 and Parkinson's disease: a systematic review and meta-analysis","volume":"123","author":"Afraie","year":"2023","journal-title":"Acta Neurol Belg"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10072-021-05756-4","article-title":"Parkinson's disease and COVID-19: a systematic review and meta-analysis","volume":"43","author":"Khoshnood","year":"2022","journal-title":"Neurol Sci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"102163","DOI":"10.1016\/j.msard.2020.102163","article-title":"Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment","volume":"42","author":"Rejdak","year":"2020","journal-title":"Mult Scler Relat Disord"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1393888\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T04:54:18Z","timestamp":1719550458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1393888\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":35,"alternative-id":["10.3389\/fneur.2024.1393888"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1393888","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"article-number":"1393888"}}